Table 6.

In vitro skin permeation of OMC and BMBM from vehicle 1–6 after a single application: cumulative amount permeated after 24 h (Q₂₄ ± S.D.), percentage of dose permeated after 24 h (% D), flux through the skin (flux ± S.D.) and lag time.

Vehicle	UV-Filter	Q24 ± S.D. (μg/cm2)	% Dose	Flux (μg/cm2/h)	Lag Time (h)
1	OMC	27.24 ± 3.23	2.72	3.09 ± 0.28	0.20
	BMBM	1.04 ± 0.10	0.52	N.DT.2	N.DT.
2	OMC	27.50 ± 3.96	2.75	3.20 ±0.29	0.11
	BMBM	1.06 ±0.09	0.53	N.DT.	N.DT.
3	OMC	29.85 ± 4.14	2.99	3.80 ± 0.35	0.15
	BMBM	0.57 ± 0.15	0.28	N.DT.	N.DT.
4	OMC	16.64 ± 2.37	1.66	3.07 ± 0.35	0.41
	BMBM	N.D. 2	N.DT.	N.DT.	N.DT.
5	OMC	46.63 ± 6.91	4.66	4.02 ± 0.39	0.17
	BMBM	0.73 ± 0.21	0.36	N.DT.	N.DT.
6	OMC	N.D. 1	N.DT.	N.DT.	N.DT.
	BMBM	N.D.	N.DT.	N.DT.	N.DT.

¹ N.D. = Not detectable in the receptor phase; ² N.DT. = not determinable.